Stem Cell Injections for Back Pain: What the Evidence Shows

Chronic low back pain is one of the most common reasons people seek care, and one of the most frustrating to treat when physical therapy, injections, and medication only bring short-term relief. Over the past decade, researchers have studied whether stem cell injections can calm inflammation and support healing in degenerated discs and joints of the spine, offering an alternative to long-term medication or invasive surgery. Here’s what the research actually shows, where the evidence is strongest, and how this fits into a broader regenerative medicine approach to chronic pain.

What are stem cell injections for back pain?

Stem cell injections for back pain involve placing cells with regenerative signaling properties into or around a painful spinal structure, such as a degenerated disc, a facet joint, or the sacroiliac joint. The goal isn’t to “grow a new disc.” Instead, these cells are believed to release growth factors and anti-inflammatory signals that can reduce local inflammation, support the surrounding tissue environment, and potentially slow the cycle of irritation that keeps chronic back pain going.

It’s worth being precise about terminology here, because clinics vary widely in what they offer. Some research trials use bone marrow or fat harvested from the same patient. At Utah Stem Cells, we do not use autologous (patient’s own) stem cells harvested from bone marrow or fat. Our regenerative injections use cells from donated umbilical cord and amniotic tissue, which are processed and screened in a laboratory, often paired with PRP (platelet-rich plasma) drawn from the patient’s own blood. Understanding this distinction matters when you’re comparing options or reading a study online — not all “stem cell” injections are the same product.

What does the research actually show?

The evidence base for stem cell injections in back pain is still developing, and it’s important to separate promising signals from proof.

• A phase II trial that enrolled 100 patients with moderate to severe discogenic low back pain found that a single injection into the affected disc reduced pain by more than 50% on average at 12 months, with less reliance on pain medication and fewer subsequent spine interventions compared to a control group. This trial used donor-derived mesenchymal precursor cells rather than the patient’s own tissue.
• A systematic review covering a handful of smaller studies (both randomized trials and case series) between 2015 and 2021 found that stem cell injections reduced pain scores in people with chronic discogenic back pain, but the author called for larger trials with more consistent protocols before drawing firm conclusions.
• A 2025 meta-analysis pooling several randomized trials in chronic low back pain patients reported statistically significant improvements in pain and function compared to control groups, without a significant difference in serious adverse events.
• Smaller single-center studies using bone marrow concentrate have reported similar pain improvements, though some of this research was conducted by the clinics offering the treatment, which is a conflict of interest worth factoring into how much weight you give the results.

The honest summary: multiple independent lines of research point in the same direction — reduced pain and improved function for a meaningful share of patients with chronic, non-surgical back pain — but study sizes are still modest, protocols vary considerably from one trial to the next, and no stem cell injection for back pain currently carries full FDA approval as a disease-modifying treatment. Results vary from patient to patient, and nobody can promise you’ll be a responder.

How does this compare to other back pain options?

Most people arrive at regenerative options after trying — and getting limited relief from — the usual first-line treatments:

• Physical therapy and activity modification remain the foundation of back pain care and should usually be tried first or alongside other treatments.
• Cortisone (steroid) injections can reduce inflammation quickly but tend to offer short-term relief and are not meant for repeated long-term use.
• PRP injections use concentrated platelets from your own blood to deliver growth factors to an injured area; they’re a reasonable, well-tolerated option, sometimes combined with regenerative cell injections for a layered approach.
• Surgery (fusion, discectomy, decompression) is appropriate for specific structural problems like severe stenosis, instability, or nerve compression, but it’s a bigger step with a longer recovery, and isn’t typically the first option for diffuse discogenic pain.
• Stem cell injections sit in between: less invasive than surgery, with a biological mechanism distinct from steroids, but still an evolving field without the decades of outcome data that back surgery or physical therapy have.

Who is a candidate?

Stem cell injections tend to be considered for people with chronic (not acute) back pain that hasn’t fully responded to conservative care, especially when imaging points to disc degeneration, facet joint changes, or sacroiliac joint dysfunction rather than a clear surgical emergency like cauda equina syndrome or progressive neurological loss. People with active infection, certain cancers, or uncontrolled autoimmune disease are generally not good candidates.

Because every spine and every pain pattern is different, candidacy isn’t something you can determine from a blog post or a symptom checklist. It requires a physician to review your history, prior treatments, and imaging. At Utah Stem Cells, that evaluation is where every treatment plan starts.

What to expect from Utah Stem Cells

Dr. William Cimikoski’s approach is physician-led and evidence-informed: we talk through what the research does and doesn’t support for your specific situation before recommending anything. If regenerative injections are appropriate, treatment typically involves:

1. A physical exam and review of imaging/prior treatment history.
2. A conversation about realistic expectations — including the fact that this is not a guaranteed fix and is not currently an FDA-approved cure for disc degeneration.
3. An in-office injection using donated umbilical or amniotic tissue-derived cells, PRP, or a combination, depending on your presentation.
4. Follow-up to track your response over the following weeks and months, since improvement with regenerative approaches tends to build gradually rather than appear overnight.

We’d rather tell you honestly that you may not be a good candidate than oversell a treatment that hasn’t been proven to help your specific condition. If you’re also dealing with neck pain or joint symptoms elsewhere, those can often be evaluated in the same visit.

Frequently asked questions

Are stem cell injections for back pain FDA-approved?

No. No stem cell product is currently FDA-approved as a disease-modifying treatment for back pain or disc degeneration. Some centers participate in clinical trials; outside of a trial, these are considered investigational, and you should ask any clinic directly about the regulatory status of what they’re offering. For more on this, see our guide to FDA status.

How is this different from a cortisone shot?

Cortisone reduces inflammation quickly but doesn’t address the underlying tissue environment, and repeated use carries its own risks. Regenerative injections aim to support tissue healing signals over a longer time frame, though the evidence for long-term structural change is still limited.

Does Utah Stem Cells use my own stem cells?

No. We use cells derived from donated, laboratory-screened umbilical cord and amniotic tissue, not cells harvested from your bone marrow or fat. When PRP is part of your plan, that component does come from your own blood.

How many injections will I need?

This varies by patient, diagnosis, and response. Some protocols involve a single injection with follow-up monitoring; others involve a short series. Your physician will outline a specific plan after your evaluation rather than following a one-size-fits-all schedule.

Is this treatment covered by insurance?

Coverage for regenerative orthopedic injections varies by insurer and is often limited, since these treatments are still considered investigational for most diagnoses. Our team can walk you through what applies to your plan during consultation.

What are the risks?

As with any injection, risks can include infection, bleeding, or temporary soreness at the injection site. Because this field is still developing, long-term risks and benefits are not as well established as they are for older treatments like physical therapy or surgery. A thorough evaluation helps weigh those risks against your specific situation.

Choosing where to get this done

If you’re researching this treatment, it’s worth reading about red flags to watch for when choosing a stem cell clinic before committing anywhere. A clinic that’s upfront about study limitations, cell sourcing, and the fact that outcomes vary is generally a better sign than one promising guaranteed results.

This article is for general education and is not medical advice or a promise of any particular outcome. Stem cell injections for back pain are not an FDA-approved cure for disc degeneration, and individual results vary. A physician must evaluate your specific history and imaging to determine whether this or any treatment is appropriate for you.